-46%

est. 2Y upside i

HealthcareSeries B

Camber is on a mission to revolutionize the healthcare reimbursement system by reducing the significant administrative burden on healthcare clinics and families. Camber’s proprietary platform increases the speed, accuracy and efficiency of healthcare claims processing and payments, enabling providers to deliver high quality healthcare to more patients.

Rank

#943

Sector

Healthcare Technology

Est. Liquidity

~4Y

Data Quality

Data: High

Camber presents a strong upside opportunity driven by its AI-powered solution in the rapidly growing behavioral health RCM market.

Last updated: March 10, 2026

Bull (28%)+300%

Camber significantly expands its market penetration in behavioral health and successfully enters new specialized healthcare segments like home health and long-term care, leveraging its AI-driven platform to achieve superior efficiency and first-pass collection rates. This leads to rapid revenue growth, justifying a valuation of $720M+ by 2028, representing a 3x return from the current valuation.

Base (44%)+50%

Camber maintains its strong position within the behavioral health RCM market, growing steadily by capturing additional clinics and expanding its feature set. While facing competition, its specialized focus and AI moat allow for continued growth, leading to a valuation of approximately $270M by 2028, a 50% increase from the current valuation.

Bear (28%)-60%

Increased competition from well-funded incumbents like Optum and Coronis Health, who expand aggressively into the behavioral health RCM space with advanced AI offerings, erodes Camber's market share and pricing power. This, combined with potential regulatory hurdles or slower-than-expected adoption, results in a down round or an acquisition at a significantly reduced valuation of $72M, wiping out most common stock value given the substantial liquidation preferences.

Est. time to liquidity~3.5 years

Preference Stack Risk

severe

Funding Intensity

28%

Investors have contributed $73.6M, which represents 40.89% of the current $180M valuation. In a liquidation event at or below the current valuation, common stock holders would face significant dilution due to preferred share liquidation preferences.

Dilution Risk

high

As a Series B company, Camber will likely require additional funding rounds (e.g., Series C, D) before an IPO or acquisition, which will dilute existing common stock holders.

Secondary Liquidity

none

There is no public information indicating active secondary markets or tender offers for Camber's equity.

Questions to Ask at the Interview

Strategic questions based on Camber's data — designed to show you've done your homework.

  • 1

    “Given that dominant players like Optum and Coronis Health are actively expanding their AI-driven RCM solutions, including into specialized niches like behavioral health, how does Camber plan to maintain its strong competitive moat and differentiate its offering over the next 2-3 years?”

  • 2

    “Camber operates in a rapidly growing behavioral health RCM market, projected to grow at 12.8-17.1% CAGR. What are the key metrics the company is tracking to measure its market penetration and growth, and what are the strategic priorities to scale revenue significantly beyond its current base?”

  • 3

    “With $73.6M in total funding and a $180M valuation, indicating a significant preference stack, how is the company thinking about a liquidity event timeline for employees within a 2-year horizon, and what are the plans to ensure meaningful returns for common shareholders?”

Community

Valuation Sentiment

Our model estimates -46% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.